RNA Binding Proteins Regulating Cancer Metastasis

17 concepts10 papers1 proposal

A cell does not achieve metastatic capability simply by turning genes on or off at the DNA level. Once messenger RNA (mRNA) is transcribed, a sophisticated layer of post-transcriptional regulation dictates how long that mRNA persists, how it is spliced, and how it interacts with other cellular components. RNA-binding proteins (RBPs) serve as the critical executioners of this post-transcriptional landscape. When the expression or function of these proteins is altered, cancer cells can acquire selectable metastatic traits, enabling them to proliferate, invade tissues, and migrate to distant organs.

Shaping the Transcriptome via Alternative Splicing

One of the primary mechanisms through which RBPs control cancer progression is alternative splicing. By selectively including or excluding specific exons during RNA processing, a single gene can produce multiple protein isoforms with entirely different, or even opposing, functional properties.

Li et al. demonstrated this principle by showing how the RBP ESRP1 acts as a suppressor of metastasis in gastric cancer. ESRP1 drives the alternative splicing of the CLSTN1 gene, generating a specific shorter isoform. This shorter protein stabilizes cell adhesion structures and promotes the degradation of β-catenin, which ultimately prevents cancer cells from breaking away and migrating.

Conversely, losing an RBP that maintains normal splicing can unleash aggressive cellular behaviors. Vanharanta et al. discovered that the loss of the multifunctional RBP RBM47 allows breast cancer cells to transition into a pro-metastatic state. Without RBM47, alterations in mRNA splicing and stability disrupt key regulatory pathways, such as those involving the Wnt-signaling inhibitor DKK1, allowing metastatic traits to be selected for during tumor progression.

Tuning Gene Expression via mRNA Stability

Beyond altering the structure of proteins through splicing, RBPs directly dictate the lifespan of transcripts. By binding to specific sequences on an mRNA molecule, an RBP can either protect it from degradation or accelerate its decay, acting as a rheostat for gene expression.

This mechanism is vital for keeping metastasis-suppressing pathways active. For instance, Zhang et al. revealed that the protein Arid4a functions as a metastasis suppressor in breast cancer by targeting MTSS1, a gene known to inhibit tumor spread. Arid4a binds to and enhances the stability of MTSS1 mRNA, ensuring the cell maintains sufficient levels of this protective protein to prevent invasion.

Crosstalk with Non-Coding RNAs and Signaling Pathways

RBPs do not operate in isolation; they form dense regulatory networks by interacting with various non-coding RNAs (ncRNAs) and intracellular signaling molecules. These interactions create complex feedback loops that can amplify or suppress oncogenic signals.

On the RNA level, RBPs interface with circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and microRNAs (miRNAs):

  • Okholm et al. mapped transcriptome-wide interactions to show that circRNAs actively engage with RBPs, a process that influences both the biogenesis of the circRNAs themselves and the expression of downstream cancer pathways.
  • Wu et al. highlighted the RBP hnRNPK, which interacts with lncRNAs and miRNAs to regulate gene expression. When these hnRNPK-ncRNA interactions are dysregulated, normal cellular functions break down, contributing to development and progression of cancer.

In addition to binding RNA, some RBPs physically interact with cytoplasmic signaling cascades to drive aggressive behaviors. Liu et al. demonstrated that the RBP G3BP1 directly binds to and activates the signaling molecule PKCζ. This interaction serves as a critical bridge between RNA-binding functions and intracellular signaling, accelerating breast cancer cell proliferation and metastasis.

Clinical Mapping and Biomarker Potential

Because RBP dysregulation fundamentally alters the molecular state of a cell, the expression patterns of these proteins serve as precise indicators of tumor advancement and patient prognosis.

Lian et al. analyzed the co-expression networks of altered RBPs alongside transcription factors and lncRNAs, finding that RBP expression profiles significantly correlate with clinical TNM staging—specifically the metastasis (M) and lymph node (N) stages. This indicates that RBP expression can serve as a direct molecular indicator of how far a tumor has advanced.

This pan-cancer relevance is further supported by Machnik et al., who identified a specific signature of cancer-associated KRAB-ZNF genes and their splicing variants that are consistently overexpressed across a wide range of cancer types and correlate with patient survival. Furthermore, the influence of RBPs extends to the tumor microenvironment; Wei et al. found that elevated expression of RBM47 in gliomas correlates with a poorer prognosis and shapes the immune landscape by enriching for immunosuppressive M2 macrophages.

To systematically organize these findings, Liao et al. developed EuRBPDB, a comprehensive database that catalogs the functional annotations, mutations, expression changes, and clinical survival correlations of eukaryotic RBPs. By unifying these diverse data points, the database provides a foundational resource for identifying which RBPs can be leveraged as clinical biomarkers or targeted for novel therapeutic interventions.

History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_role_of_rna_binding_proteins_in_breast_c_d54d3ebb,
  title = {role of RNA-binding proteins in breast cancer metastasis},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/role-of-rna-binding-proteins-in-breast-cancer-metastasis/rdr_d54d3ebb680e4fcf872901f869947e08},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}

This exact version (version 1, frozen text):

@misc{lacuna_role_of_rna_binding_proteins_in_breast_c_d54d3ebb_v1,
  title = {role of RNA-binding proteins in breast cancer metastasis},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/role-of-rna-binding-proteins-in-breast-cancer-metastasis/rdr_d54d3ebb680e4fcf872901f869947e08/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake